img

Global OTC Medicine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Medicine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global OTC Medicine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Gastrointestinal Tract accounting for % of the OTC Medicine global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Pharmacy segment is altered to an % CAGR throughout this forecast period.
The global key companies of OTC Medicine include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer, Aktienge, Sanofi and Pfizer, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States OTC Medicine market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe OTC Medicine landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global OTC Medicine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global OTC Medicine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global OTC Medicine market. Readers of the report can become informed about current and future trends of the global OTC Medicine market and how they will impact market growth during the forecast period.



By Company


Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Segment by Type
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others

Segment by Application


Pharmacy
Hospital Pharmacy
Online Retailer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of OTC Medicine in global and regional level.
Chapter 3Detailed analysis of OTC Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Medicine revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Gastrointestinal Tract
1.2.3 Dermatology
1.2.4 Otolaryngology
1.2.5 Nutrition/Vitamins
1.2.6 Others
1.3 Market by Application
1.3.1 Global OTC Medicine Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Online Retailer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global OTC Medicine Market Size (2018-2034)
2.2 OTC Medicine Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global OTC Medicine Market Size by Region (2018-2024)
2.4 Global OTC Medicine Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 OTC Medicine Countries Ranking by Market Size
3 OTC Medicine Competitive by Company
3.1 Global OTC Medicine Revenue by Players
3.1.1 Global OTC Medicine Revenue by Players (2018-2024)
3.1.2 Global OTC Medicine Market Share by Players (2018-2024)
3.2 Global OTC Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by OTC Medicine Revenue
3.4 Global OTC Medicine Market Concentration Ratio
3.4.1 Global OTC Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Medicine Revenue in 2022
3.5 Global Key Players of OTC Medicine Head office and Area Served
3.6 Global Key Players of OTC Medicine, Product and Application
3.7 Global Key Players of OTC Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global OTC Medicine Breakdown Data by Type
4.1 Global OTC Medicine Historic Revenue by Type (2018-2024)
4.2 Global OTC Medicine Forecasted Revenue by Type (2024-2034)
5 Global OTC Medicine Breakdown Data by Application
5.1 Global OTC Medicine Historic Market Size by Application (2018-2024)
5.2 Global OTC Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America OTC Medicine Revenue by Company (2021-2024)
6.2 North America OTC Medicine Revenue by Type (2018-2034)
6.3 North America OTC Medicine Revenue by Application (2018-2034)
6.4 North America OTC Medicine Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe OTC Medicine Revenue by Company (2021-2024)
7.2 Europe OTC Medicine Revenue by Type (2018-2034)
7.3 Europe OTC Medicine Revenue by Application (2018-2034)
7.4 Europe OTC Medicine Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific OTC Medicine Revenue by Company (2021-2024)
8.2 Asia Pacific OTC Medicine Revenue by Type (2018-2034)
8.3 Asia Pacific OTC Medicine Revenue by Application (2018-2034)
8.4 Asia Pacific OTC Medicine Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America OTC Medicine Revenue by Company (2021-2024)
9.2 Latin America OTC Medicine Revenue by Type (2018-2034)
9.3 Latin America OTC Medicine Revenue by Application (2018-2034)
9.4 Latin America OTC Medicine Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa OTC Medicine Revenue by Company (2021-2024)
10.2 Middle East and Africa OTC Medicine Revenue by Type (2018-2034)
10.3 Middle East and Africa OTC Medicine Revenue by Application (2018-2034)
10.4 Middle East and Africa OTC Medicine Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Procter & Gamble
11.1.1 Procter & Gamble Company Details
11.1.2 Procter & Gamble Business Overview
11.1.3 Procter & Gamble OTC Medicine Products and Services
11.1.4 Procter & Gamble OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.1.5 Procter & Gamble OTC Medicine SWOT Analysis
11.1.6 Procter & Gamble Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson OTC Medicine Products and Services
11.2.4 Johnson & Johnson OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.2.5 Johnson & Johnson OTC Medicine SWOT Analysis
11.2.6 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc OTC Medicine Products and Services
11.3.4 GlaxoSmithKline Plc OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.3.5 GlaxoSmithKline Plc OTC Medicine SWOT Analysis
11.3.6 GlaxoSmithKline Plc Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories OTC Medicine Products and Services
11.4.4 Abbott Laboratories OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.4.5 Abbott Laboratories OTC Medicine SWOT Analysis
11.4.6 Abbott Laboratories Recent Development
11.5 Amway Corporation
11.5.1 Amway Corporation Company Details
11.5.2 Amway Corporation Business Overview
11.5.3 Amway Corporation OTC Medicine Products and Services
11.5.4 Amway Corporation OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.5.5 Amway Corporation OTC Medicine SWOT Analysis
11.5.6 Amway Corporation Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer OTC Medicine Products and Services
11.6.4 Bayer OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.6.5 Bayer OTC Medicine SWOT Analysis
11.6.6 Bayer Recent Development
11.7 Aktienge
11.7.1 Aktienge Company Details
11.7.2 Aktienge Business Overview
11.7.3 Aktienge OTC Medicine Products and Services
11.7.4 Aktienge OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.7.5 Aktienge OTC Medicine SWOT Analysis
11.7.6 Aktienge Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi OTC Medicine Products and Services
11.8.4 Sanofi OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.8.5 Sanofi OTC Medicine SWOT Analysis
11.8.6 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer OTC Medicine Products and Services
11.9.4 Pfizer OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.9.5 Pfizer OTC Medicine SWOT Analysis
11.9.6 Pfizer Recent Development
11.10 Reckitt Benckiser Group
11.10.1 Reckitt Benckiser Group Company Details
11.10.2 Reckitt Benckiser Group Business Overview
11.10.3 Reckitt Benckiser Group OTC Medicine Products and Services
11.10.4 Reckitt Benckiser Group OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.10.5 Reckitt Benckiser Group OTC Medicine SWOT Analysis
11.10.6 Reckitt Benckiser Group Recent Development
11.11 Church & Dwight
11.11.1 Church & Dwight Company Details
11.11.2 Church & Dwight Business Overview
11.11.3 Church & Dwight OTC Medicine Products and Services
11.11.4 Church & Dwight OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.11.5 Church & Dwight Recent Development
11.12 Bayer HealthCare
11.12.1 Bayer HealthCare Company Details
11.12.2 Bayer HealthCare Business Overview
11.12.3 Bayer HealthCare OTC Medicine Products and Services
11.12.4 Bayer HealthCare OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.12.5 Bayer HealthCare Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca OTC Medicine Products and Services
11.13.4 AstraZeneca OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.13.5 AstraZeneca Recent Development
11.14 BioGaia
11.14.1 BioGaia Company Details
11.14.2 BioGaia Business Overview
11.14.3 BioGaia OTC Medicine Products and Services
11.14.4 BioGaia OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.14.5 BioGaia Recent Development
11.15 Bristol Myers Squibb
11.15.1 Bristol Myers Squibb Company Details
11.15.2 Bristol Myers Squibb Business Overview
11.15.3 Bristol Myers Squibb OTC Medicine Products and Services
11.15.4 Bristol Myers Squibb OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.15.5 Bristol Myers Squibb Recent Development
11.16 Chr. Hansen
11.16.1 Chr. Hansen Company Details
11.16.2 Chr. Hansen Business Overview
11.16.3 Chr. Hansen OTC Medicine Products and Services
11.16.4 Chr. Hansen OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.16.5 Chr. Hansen Recent Development
11.17 Cipla
11.17.1 Cipla Company Details
11.17.2 Cipla Business Overview
11.17.3 Cipla OTC Medicine Products and Services
11.17.4 Cipla OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.17.5 Cipla Recent Development
11.18 CoLucid
11.18.1 CoLucid Company Details
11.18.2 CoLucid Business Overview
11.18.3 CoLucid OTC Medicine Products and Services
11.18.4 CoLucid OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.18.5 CoLucid Recent Development
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Details
11.19.2 Daiichi Sankyo Business Overview
11.19.3 Daiichi Sankyo OTC Medicine Products and Services
11.19.4 Daiichi Sankyo OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.19.5 Daiichi Sankyo Recent Development
11.20 Friggs
11.20.1 Friggs Company Details
11.20.2 Friggs Business Overview
11.20.3 Friggs OTC Medicine Products and Services
11.20.4 Friggs OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.20.5 Friggs Recent Development
11.21 DSM
11.21.1 DSM Company Details
11.21.2 DSM Business Overview
11.21.3 DSM OTC Medicine Products and Services
11.21.4 DSM OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.21.5 DSM Recent Development
11.22 Eisai
11.22.1 Eisai Company Details
11.22.2 Eisai Business Overview
11.22.3 Eisai OTC Medicine Products and Services
11.22.4 Eisai OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.22.5 Eisai Recent Development
11.23 Eli Lilly
11.23.1 Eli Lilly Company Details
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly OTC Medicine Products and Services
11.23.4 Eli Lilly OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.23.5 Eli Lilly Recent Development
11.24 Herbalife
11.24.1 Herbalife Company Details
11.24.2 Herbalife Business Overview
11.24.3 Herbalife OTC Medicine Products and Services
11.24.4 Herbalife OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.24.5 Herbalife Recent Development
11.25 Euradite
11.25.1 Euradite Company Details
11.25.2 Euradite Business Overview
11.25.3 Euradite OTC Medicine Products and Services
11.25.4 Euradite OTC Medicine Revenue in OTC Medicine Business (2018-2024)
11.25.5 Euradite Recent Development
12 OTC Medicine Market Dynamics
12.1 OTC Medicine Industry Trends
12.2 OTC Medicine Market Drivers
12.3 OTC Medicine Market Challenges
12.4 OTC Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global OTC Medicine Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Gastrointestinal Tract
Table 3. Key Players of Dermatology
Table 4. Key Players of Otolaryngology
Table 5. Key Players of Nutrition/Vitamins
Table 6. Key Players of Others
Table 7. Global OTC Medicine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 8. Global OTC Medicine Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 9. Global OTC Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global OTC Medicine Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 11. Global OTC Medicine Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 12. Global OTC Medicine Revenue by Players (2018-2024) & (US$ Million)
Table 13. Global OTC Medicine Market Share by Players (2018-2024)
Table 14. Global Top OTC Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Medicine as of 2022)
Table 15. Ranking of Global Top OTC Medicine Companies by Revenue (US$ Million) in 2022
Table 16. Global 5 Largest Players Market Share by OTC Medicine Revenue (CR5 and HHI) & (2018-2024)
Table 17. Global Key Players of OTC Medicine, Headquarters and Area Served
Table 18. Global Key Players of OTC Medicine, Product and Application
Table 19. Global Key Players of OTC Medicine, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global OTC Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 22. Global OTC Medicine Revenue Market Share by Type (2018-2024)
Table 23. Global OTC Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 24. Global OTC Medicine Revenue Market Share by Type (2024-2034)
Table 25. Global OTC Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 26. Global OTC Medicine Revenue Market Share by Application (2018-2024)
Table 27. Global OTC Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 28. Global OTC Medicine Revenue Market Share by Application (2024-2034)
Table 29. North America OTC Medicine Revenue by Company (2021-2024) & (US$ Million)
Table 30. North America OTC Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 31. North America OTC Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 32. North America OTC Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 33. North America OTC Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 34. North America OTC Medicine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 35. North America OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 36. North America OTC Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 37. Europe OTC Medicine Revenue by Company (2021-2024) & (US$ Million)
Table 38. Europe OTC Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 39. Europe OTC Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 40. Europe OTC Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 41. Europe OTC Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 42. Europe OTC Medicine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Europe OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Europe OTC Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Asia Pacific OTC Medicine Revenue by Company (2021-2024) & (US$ Million)
Table 46. Asia Pacific OTC Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 47. Asia Pacific OTC Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 48. Asia Pacific OTC Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 49. Asia Pacific OTC Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 50. Asia-Pacific OTC Medicine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 51. Asia Pacific OTC Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 52. Asia Pacific OTC Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 53. Latin America OTC Medicine Revenue by Company (2021-2024) & (US$ Million)
Table 54. Latin America OTC Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 55. Latin America OTC Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 56. Latin America OTC Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 57. Latin America OTC Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 58. Latin America OTC Medicine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 59. Latin America OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 60. Latin America OTC Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 61. Middle East and Africa OTC Medicine Revenue by Company (2021-2024) & (US$ Million)
Table 62. Middle East and Africa OTC Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Middle East and Africa OTC Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 64. Middle East and Africa OTC Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa OTC Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 66. Middle East and Africa OTC Medicine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 67. Middle East and Africa OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 68. Middle East and Africa OTC Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 69. Procter & Gamble Company Details
Table 70. Procter & Gamble Business Overview
Table 71. Procter & Gamble OTC Medicine Product and Services
Table 72. Procter & Gamble OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 73. Procter & Gamble OTC Medicine SWOT Analysis
Table 74. Procter & Gamble Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson OTC Medicine Product and Services
Table 78. Johnson & Johnson OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 79. Johnson & Johnson OTC Medicine SWOT Analysis
Table 80. Johnson & Johnson Recent Development
Table 81. GlaxoSmithKline Plc Company Details
Table 82. GlaxoSmithKline Plc Business Overview
Table 83. GlaxoSmithKline Plc OTC Medicine Product and Services
Table 84. GlaxoSmithKline Plc OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 85. GlaxoSmithKline Plc OTC Medicine SWOT Analysis
Table 86. GlaxoSmithKline Plc Recent Development
Table 87. Abbott Laboratories Company Details
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories OTC Medicine Product and Services
Table 90. Abbott Laboratories OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 91. Abbott Laboratories OTC Medicine SWOT Analysis
Table 92. Abbott Laboratories Recent Development
Table 93. Amway Corporation Company Details
Table 94. Amway Corporation Business Overview
Table 95. Amway Corporation OTC Medicine Product and Services
Table 96. Amway Corporation OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 97. Amway Corporation OTC Medicine SWOT Analysis
Table 98. Amway Corporation Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer OTC Medicine Product and Services
Table 102. Bayer OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 103. Bayer OTC Medicine SWOT Analysis
Table 104. Bayer Recent Development
Table 105. Aktienge Company Details
Table 106. Aktienge Business Overview
Table 107. Aktienge OTC Medicine Product and Services
Table 108. Aktienge OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 109. Aktienge OTC Medicine SWOT Analysis
Table 110. Aktienge Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi OTC Medicine Product and Services
Table 114. Sanofi OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 115. Sanofi OTC Medicine SWOT Analysis
Table 116. Sanofi Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer OTC Medicine Product and Services
Table 120. Pfizer OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 121. Pfizer OTC Medicine SWOT Analysis
Table 122. Pfizer Recent Development
Table 123. Reckitt Benckiser Group Company Details
Table 124. Reckitt Benckiser Group Business Overview
Table 125. Reckitt Benckiser Group OTC Medicine Product and Services
Table 126. Reckitt Benckiser Group OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 127. Reckitt Benckiser Group OTC Medicine SWOT Analysis
Table 128. Reckitt Benckiser Group Recent Development
Table 129. Church & Dwight Company Details
Table 130. Church & Dwight Business Overview
Table 131. Church & Dwight OTC Medicine Product and Services
Table 132. Church & Dwight OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 133. Church & Dwight Recent Development
Table 134. Bayer HealthCare Company Details
Table 135. Bayer HealthCare Business Overview
Table 136. Bayer HealthCare OTC Medicine Product and Services
Table 137. Bayer HealthCare OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 138. Bayer HealthCare Recent Development
Table 139. AstraZeneca Company Details
Table 140. AstraZeneca Business Overview
Table 141. AstraZeneca OTC Medicine Product and Services
Table 142. AstraZeneca OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 143. AstraZeneca Recent Development
Table 144. BioGaia Company Details
Table 145. BioGaia Business Overview
Table 146. BioGaia OTC Medicine Product and Services
Table 147. BioGaia OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 148. BioGaia Recent Development
Table 149. Bristol Myers Squibb Company Details
Table 150. Bristol Myers Squibb Business Overview
Table 151. Bristol Myers Squibb OTC Medicine Product and Services
Table 152. Bristol Myers Squibb OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 153. Bristol Myers Squibb Recent Development
Table 154. Chr. Hansen Company Details
Table 155. Chr. Hansen Business Overview
Table 156. Chr. Hansen OTC Medicine Product and Services
Table 157. Chr. Hansen OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 158. Chr. Hansen Recent Development
Table 159. Cipla Company Details
Table 160. Cipla Business Overview
Table 161. Cipla OTC Medicine Product and Services
Table 162. Cipla OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 163. Cipla Recent Development
Table 164. CoLucid Company Details
Table 165. CoLucid Business Overview
Table 166. CoLucid OTC Medicine Product and Services
Table 167. CoLucid OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 168. CoLucid Recent Development
Table 169. Daiichi Sankyo Company Details
Table 170. Daiichi Sankyo Business Overview
Table 171. Daiichi Sankyo OTC Medicine Product and Services
Table 172. Daiichi Sankyo OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 173. Daiichi Sankyo Recent Development
Table 174. Friggs Company Details
Table 175. Friggs Business Overview
Table 176. Friggs OTC Medicine Product and Services
Table 177. Friggs OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 178. Friggs Recent Development
Table 179. DSM Company Details
Table 180. DSM Business Overview
Table 181. DSM OTC Medicine Product and Services
Table 182. DSM OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 183. DSM Recent Development
Table 184. Eisai Company Details
Table 185. Eisai Business Overview
Table 186. Eisai OTC Medicine Product and Services
Table 187. Eisai OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 188. Eisai Recent Development
Table 189. Eli Lilly Company Details
Table 190. Eli Lilly Business Overview
Table 191. Eli Lilly OTC Medicine Product and Services
Table 192. Eli Lilly OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 193. Eli Lilly Recent Development
Table 194. Herbalife Company Details
Table 195. Herbalife Business Overview
Table 196. Herbalife OTC Medicine Product and Services
Table 197. Herbalife OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 198. Herbalife Recent Development
Table 199. Euradite Company Details
Table 200. Euradite Business Overview
Table 201. Euradite OTC Medicine Product and Services
Table 202. Euradite OTC Medicine Revenue in OTC Medicine Business (2018-2024) & (US$ Million)
Table 203. Euradite Recent Development
Table 204. OTC Medicine Market Trends
Table 205. OTC Medicine Market Drivers
Table 206. OTC Medicine Market Challenges
Table 207. OTC Medicine Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. OTC Medicine Product Picture
Figure 2. Global OTC Medicine Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global OTC Medicine Market Share by Type: 2022 VS 2034
Figure 4. Gastrointestinal Tract Features
Figure 5. Dermatology Features
Figure 6. Otolaryngology Features
Figure 7. Nutrition/Vitamins Features
Figure 8. Others Features
Figure 9. Global OTC Medicine Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 10. Global OTC Medicine Market Share by Application: 2022 VS 2034
Figure 11. Pharmacy
Figure 12. Hospital Pharmacy
Figure 13. Online Retailer
Figure 14. Others
Figure 15. OTC Medicine Report Years Considered
Figure 16. Global OTC Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global OTC Medicine Market Size 2018-2034 (US$ Million)
Figure 18. Global OTC Medicine Market Size Market Share by Region: 2022 VS 2034
Figure 19. Global OTC Medicine Revenue Market Share by Region in 2018 VS 2022
Figure 20. Global OTC Medicine Revenue Market Share Forecast by Region (2024-2034)
Figure 21. Global Top 10 OTC Medicine Countries Ranking by Market Size (US$ Million) in 2022
Figure 22. Global OTC Medicine Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 23. Global OTC Medicine Market Share by Players in 2022
Figure 24. Global Top OTC Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Medicine as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by OTC Medicine Revenue in 2022
Figure 26. North America OTC Medicine Revenue Market Share by Company in 2022
Figure 27. North America OTC Medicine Revenue Market Share by Type (2018-2034)
Figure 28. North America OTC Medicine Revenue Market Share by Application (2018-2034)
Figure 29. North America OTC Medicine Revenue Share by Country (2018-2034)
Figure 30. United States OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 31. Canada OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 32. Europe OTC Medicine Revenue Market Share by Company in 2022
Figure 33. Europe OTC Medicine Revenue Market Share by Type (2018-2034)
Figure 34. Europe OTC Medicine Revenue Market Share by Application (2018-2034)
Figure 35. Europe OTC Medicine Revenue Share by Country (2018-2034)
Figure 36. Germany OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 37. France OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 38. U.K. OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 39. Italy OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 40. Russia OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 41. Asia Pacific OTC Medicine Revenue Market Share by Company in 2022
Figure 42. Asia Pacific OTC Medicine Revenue Market Share by Type (2018-2034)
Figure 43. Asia Pacific OTC Medicine Revenue Market Share by Application (2018-2034)
Figure 44. Asia Pacific OTC Medicine Revenue Share by Region (2018-2034)
Figure 45. China OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 46. Japan OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 47. South Korea OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 48. India OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 49. Australia OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 50. China Taiwan OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 51. Indonesia OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 52. Thailand OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 53. Malaysia OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 54. Latin America OTC Medicine Revenue Market Share by Company in 2022
Figure 55. Latin America OTC Medicine Revenue Market Share by Type (2018-2034)
Figure 56. Latin America OTC Medicine Revenue Market Share by Application (2018-2034)
Figure 57. Latin America OTC Medicine Revenue Share by Country (2018-2034)
Figure 58. Mexico OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 59. Brazil OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 60. Argentina OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 61. Middle East and Africa OTC Medicine Revenue Market Share by Company in 2022
Figure 62. Middle East and Africa OTC Medicine Revenue Market Share by Type (2018-2034)
Figure 63. Middle East and Africa OTC Medicine Revenue Market Share by Application (2018-2034)
Figure 64. Middle East and Africa OTC Medicine Revenue Share by Country (2018-2034)
Figure 65. Turkey OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 66. Saudi Arabia OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 67. UAE OTC Medicine Revenue (2018-2034) & (US$ Million)
Figure 68. Procter & Gamble Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 69. Johnson & Johnson Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 70. GlaxoSmithKline Plc Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 71. Abbott Laboratories Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 72. Amway Corporation Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 73. Bayer Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 74. Aktienge Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 75. Sanofi Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 76. Pfizer Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 77. Reckitt Benckiser Group Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 78. Church & Dwight Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 79. Bayer HealthCare Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 80. AstraZeneca Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 81. BioGaia Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 82. Bristol Myers Squibb Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 83. Chr. Hansen Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 84. Cipla Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 85. CoLucid Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 86. Daiichi Sankyo Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 87. Friggs Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 88. DSM Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 89. Eisai Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 90. Eli Lilly Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 91. Herbalife Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 92. Euradite Revenue Growth Rate in OTC Medicine Business (2018-2024)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed